JSH-150 : Pharmacokinetic Drug Evaluation of Ribociclib for the Treatment of Metastatic, Hormone-Positive Breast Cancer
Peptides Price
A gene coding for a selectable marker such as antibiotic resistance is also incorporated into the vector.
JSH-150 : Pharmacokinetic Drug Evaluation of Ribociclib for the Treatment of Metastatic, Hormone-Positive Breast Cancer